Validating the Effect og Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The aim is to investigate the efficacy of mirtazapine and ondansetron as treatment for
hyperemesis gravidarum(HG).
The setup is a double-blind multicenter trial where patients suffering from HG will be
randomized to treatment with either mirtazapine, ondansetron or placebo (1:1:1).
Phase:
Phase 2
Details
Lead Sponsor:
Nordsjaellands Hospital
Collaborators:
Aalborg Universitetshospital Aalborg University Hospital Aarhus University Hospital Bispebjerg Hospital Herlev and Gentofte Hospital Hvidovre University Hospital Kolding Sygehus Odense University Hospital Regionernes Medicinpulje Rigshospitalet, Denmark